Shandong Sinobioway Biomedicine (SHE:002581), through unit Shandong Yandu Biotechnology, signed a 54 million yuan purchase deal to buy materials for its human nerve growth factor eye drops, according to a Shenzhen Stock Exchange disclosure on Wednesday.
Under the deal, Yandu Biotechnology will purchase storage liquid and chromatography systems, fillers, and reaction bags from Jiangsu Suhao Innovation Technology Group, the Chinese pharmaceutical company said.
The amount included nearly 14 million yuan for the fillers and reaction bags and around 40 million yuan for the storage liquid and chromatography systems.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。